UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000042066
Receipt number R000046680
Scientific Title Clinical studies for the prevention of postoperative delirium in oral cancer
Date of disclosure of the study information 2020/10/09
Last modified on 2020/10/09 18:31:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Clinical studies for the prevention of postoperative delirium in oral cancer

Acronym

Prevention of Oral Cancer Postoperative Delirium

Scientific Title

Clinical studies for the prevention of postoperative delirium in oral cancer

Scientific Title:Acronym

Prevention of Oral Cancer Postoperative Delirium

Region

Japan


Condition

Condition

Oral cancer,Delirium

Classification by specialty

Psychiatry Oral surgery

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The onset of postoperative delirium is often associated with lower quality of life and longer hospital stays for postoperative patients It has been reported. In particular, surgery for oral cancer is a lengthy operation, often involving reconstructive surgery, and the postoperative period lasts several Because bed rest is required for three days, it is highly significant to prevent the development of delirium, and proactive preoperative There is a strong demand for involvement in the prevention of this disease1-6). However, it is difficult to identify the cause of delirium, and no clear method of prevention has yet been recognized. Since January 2015, our hospital has been working with physicians and nurses from the Department of Psychiatry and Psychosomatic Medicine of the Faculty of Medicine of the University of California, Berkeley, to prevent delirium. meetings are held periodically to develop a preoperative patient risk assessment sheet, and In addition, a patient and family pamphlet has been developed to provide information on early intervention for post-operative delirium The company has been aiming to build a system that will allow for the establishment of a system for the treatment of high-risk patients with delirium. In addition, from April 2020, additional points will be added during hospitalization for dealing with high-risk delirium patients. It has come to the point where further improvement is required. In this study, we clinically examined the postoperative course of patients with oral cancer and examined the factors that contribute to the development of delirium in a backward-looking It was designed to conduct research.

Basic objectives2

Others

Basic objectives -Others

Delirium is a state of cerebral insufficiency resulting from physical or drug causes, and has a background of systemic and worsened mental status. Post-operative delirium is the most commonly experienced clinical event, and it is important to detect and deal with it at an early stage It is important to prevent the onset of the disease and the severity of the disease. Although guidelines for such postoperative delirium have been reported, there is no evidence that patients with malignant oral and maxillofacial tumors are suffering from postoperative delirium There are no clear guidelines for dealing with the In this study, we conducted a study to clarify the present situation and background factors of postoperative delirium in our hospital. Planned. In this study, the surgery was performed after January 2015 at the Tokyo Medical and Dental University Dental Hospital Review of non-personal information in medical records for oral cancer patients.

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

After January 2015, the patient was diagnosed with oral cancer at the School of Dentistry Hospital and underwent surgery under general anesthesia. Patients who have been treated are eligible (approximately 200 cases per year, for a total of approximately 1600 cases). There will be no gender or age restrictions. The study will be conducted until December 31, 2022. For patients who develop postoperative delirium, the timing and duration of the onset of delirium will be studied, and the risk of delirium will be assessed. A comparison of the delirium-onset and delirium-free groups will be made to explore factors. The diagnosis of delirium will be made by a psychiatrist using the DSM-5 diagnostic criteria. The study will examine the presence or absence of postoperative delirium in the patients included in the study and the related tests Data and clinical findings will be used from the medical record. Background factors include age, gender, drinking history, smoking history, medication history, medical history, blood test results, surgical procedure, surgical Time, duration of anesthesia, blood loss, fever, insomnia, diarrhea, constipation, etc. will be considered.

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients diagnosed with oral cancer and underwent surgery under general anesthesia at our hospital between January 1, 2015, and December 31, 2022.

Key exclusion criteria

The presence or absence of post-operative delirium and related laboratory data and clinical findings are insufficient to be considered in the medical record.

Target sample size

1600


Research contact person

Name of lead principal investigator

1st name Yuji
Middle name
Last name Kabasawa

Organization

Tokyo Medical and Dental University

Division name

Graduated school

Zip code

1138510

Address

Yushima Bunkyo-ku 1-5-45,Tokyo

TEL

03-5803-4647

Email

kabasawa.ocsh@tmd.ac.jp


Public contact

Name of contact person

1st name Kabasawa
Middle name
Last name Yuji

Organization

Tokyo Medical and Dental University

Division name

Graduated school

Zip code

1138510

Address

Yushima Bunkyo-ku 1-5-45,Tokyo

TEL

03-5803-4647

Homepage URL


Email

kabasawa.ocsh@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

Tokyo Medical and Dental University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Tokyo Medical and Dental University

Address

Yushima Bunkyo-ku 1-5-45,Tokyo

Tel

03-5803-4647

Email

kabasawa.ocsh@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2020 Year 10 Month 09 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2020 Year 10 Month 08 Day

Date of IRB


Anticipated trial start date

2020 Year 10 Month 30 Day

Last follow-up date

2022 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

The presence or absence of post-operative delirium and related laboratory data and clinical findings are insufficient to be considered in the medical record. It has been widely reported that the onset of postoperative delirium is a significant factor in the deterioration of the patient's quality of life and prolonged hospital stay after surgery. In particular, oral cancer surgery, which is a lengthy operation and often involves reconstructive surgery and requires bed rest for several days after surgery, has high significance in preventing the development of delirium, and active involvement in the preoperative period is strongly required1-6). However, the cause of the onset of delirium is difficult to identify, and no clear method of prevention has yet been recognized. Since January 2015, our hospital has been holding regular meetings with physicians and nurses from the Department of Psychiatry and Psychosomatic Medicine of our university's School of Medicine on the prevention of delirium, creating an assessment sheet of patient risk behaviors before surgery, as well as a pamphlet for patients and their families to help them understand the importance of early intervention for postoperative delirium. The aim has been to build the system. In addition, from April 2020, additional points for dealing with high-risk patients with delirium during hospitalization will be added, and further enhancements will be required. The present study was designed to clinically examine the postoperative course of patients with oral cancer and to conduct a retrospective study of factors that contribute to the development of delirium.


Management information

Registered date

2020 Year 10 Month 09 Day

Last modified on

2020 Year 10 Month 09 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046680


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name